Beijing Minhai Biotechnology Co., Ltd
Registry sponsor category
Industry
- Other names
- Beijing Minhai Biotechnology Co., Ltd
- Company name
- Beijing Minhai Biotechnology Co., Ltd
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (19)
- A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine
- A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants
- A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)
- A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years
- A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)
- A Study to Evaluate Safety and Immunogenicity of Sequential Vaccination of Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) and Live Attenuated Poliomyelitis Vaccine in Healthy 2-month-old Infants
- A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)
- Clinical Trial of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Population Aged 3 to 17 Years(COVID-19)
- Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine
- Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine
- Phase I/III Clinical Trial of Adsorbed Tetanus Vaccine
- Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell)
- Safety and Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in 2 to 70 Years Old Healthy People in China
- Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine
- Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine.
- Safety and Immunogenicity of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans
- Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-dried
- Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 3 to 17 Years(COVID-19)
- The Safety Research of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans